May 19, 2026 · Form 4 insider transaction
Jenkins John Kenneth bought 3,800 shares of Corbus Pharmaceuticals Holdings, Inc. at $0.00 per share, a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 2 days after the transaction.
On May 19, 2026, 3,800 restricted stock units ("RSUs") were granted, which will be settled in shares of common stock, par value $0.0001. The RSUs will vest 100% on the one-year anniversary from the date of grant.; This amount includes 8,600 unvested RSUs subject to each grant's vesting schedule as previously reported.